ICOSLG and melanoma: It was shown in both ex vivo patient samples and in that a humanized melanoma mouse model that pDC in melanoma are directed toward a TH2 promoting phenotype by induction of the molecules OX-40L (TNFSF4) and ICOSL (inducible T cell costimulator ligand), which then drive tumor progression (143).